Viewing Study NCT00047333


Ignite Creation Date: 2025-12-25 @ 2:47 AM
Ignite Modification Date: 2026-02-28 @ 10:35 PM
Study NCT ID: NCT00047333
Status: TERMINATED
Last Update Posted: 2013-01-23
First Post: 2002-10-03
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Erlotinib in Treating Patients With Liver Cancer That Cannot be Surgically Removed
Sponsor: National Cancer Institute (NCI)
Organization:

Key Dates - Follows AllAPIJSON File Order

Start Date: 2002-08
Start Date Type: None
Primary Completion Date: 2006-01
Primary Completion Date Type: ACTUAL
Completion Date: None
Completion Date Type: None
First Submit Date: 2002-10-03
First Submit QC Date: None
Study First Post Date: 2003-01-27
Study First Post Date Type: ESTIMATED
Results First Submit Date: None
Results First Submit QC Date: None
Results First Post Date: None
Results First Post Date Type: None
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2013-01-22
Last Update Post Date: 2013-01-23
Last Update Post Date Type: ESTIMATED